A study to evaluate the effect of repeat oral doses of lamotrigine on cardiac conduction as assessed by 12-lead ECG [electrocardiogram] as compared to placebo and single oral doses of moxifloxacin
Latest Information Update: 23 Aug 2023
At a glance
- Drugs Lamotrigine (Primary) ; Moxifloxacin
- Indications Bipolar disorders; Epilepsy
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 19 Mar 2007 New trial record.